What is the dosage of Dovato?

Dovato is available in 1 dosages, including 50-300 mg Tab

What does Dovato treat?

Dovato treats Acquired Immunodeficiency Syndrome and HIV Infections

What is Dovato made of?

Dovato contains dolutegravir / lamivudine which is a Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor

How is Dovato administered?

Dovato is administered as a Oral Pill

What is Dovato mechanism of action?

Dovato mechanism of action is HIV Integrase Inhibitors, Multidrug and Toxin Extrusion Transporter 1 Inhibitors, Nucleoside Reverse Transcriptase Inhibitors or Organic Cation Transporter 2 Inhibitors

Dosage & Administration Drug label Prior authorization Financial assistance

Patient education

Dovato

(dolutegravir / lamivudine)

dolutegravir 50 MG / lamivudine 300 MG Oral Tablet [Dovato]

BLACK BOX WARNING

Dosage & administration

* Prior to or when initiating DOVATO, test patients for hepatitis B virus (HBV) infection.
* Pregnancy testing: Pregnancy testing is recommended before initiation of DOVATO in individuals of childbearing potential.
* One tablet taken orally once daily with or without food.
* The dolutegravir dose (50 mg) in DOVATO is insufficient when coadministered with carbamazepine or rifampin. If DOVATO is coadministered with carbamazepine or rifampin, take one tablet of DOVATO once daily, followed by an additional dolutegravir 50-mg tablet, approximately 12 hours from the dose of DOVATO.

drug label

Dovato prescribing information

Have more Dovato questions?

Submit MSL Request

Learn More

Need to report a Dovato issue?

ONLINE FORMReport adverse event

Learn More

prior authorization

Dovato Prior authorization resources

Complete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDCoverage Authorization Appeals

Learn More

Benefits investigation

ViiVConnect Enrollment Form

ViiVConnect Enrollment Form - Spanish

Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information

Learn More

financial assistance

Dovato Financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

ViiVConnect Enrollment Form

ViiVConnect Enrollment Form - Spanish

Viiv Healthcare Patient Assistance Program

Common Patient Assistance Program Application (CPAPA) Companion Document

Common Patient Assistance Program Application (CPAPA)

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Dovato Patient education